Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function
- PMID: 32032734
- PMCID: PMC7150649
- DOI: 10.1016/j.nbd.2020.104786
Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function
Abstract
Mutations in the human ATP13A2 gene are associated with an early-onset form of Parkinson's disease (PD) known as Kufor Rakeb Syndrome (KRS). Patients with KRS show increased iron deposition in the basal ganglia, suggesting iron toxicity-induced neurodegeneration as a potential pathogenesis associated with the ATP13A2 mutation. Previously we demonstrated that functional losses of ATP13A2 disrupt the lysosomes ability to store excess iron, leading to reduce survival of dopaminergic neuronal cells. To understand the possible mechanisms involved, we studied a Caenorhabditis elegans mutant defective in catp-6 function, an ortholog of human ATP13A2 gene. Here we show that catp-6 mutant worms have defective autophagy and lysosomal function, demonstrate characteristic PD phenotypes including reduced motor function and dysregulated iron metabolism. Additionally, these mutants have defective mitochondrial health, which is rescuable via iron chelation or mitophagy induction.
Keywords: ATP13A2; C. elegans; Catp-6; Iron chelation; Iron metabolism; Lysosomes; Mitochondrial function; Parkinson's disease; TFEB; Urolithin A.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Andreux PA, Blanco-Bose W, Ryu D, Burdet F, Ibberson M et al. , 2019. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism 1: 595–603. - PubMed
-
- Behrens MI, Bruggemann N, Chana P, Venegas P, Kagi M et al. , 2010. Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations. Mov Disord 25: 1929–1937. - PubMed
-
- Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ et al. , 2003. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256–259. - PubMed
-
- Chamoli M, Chinta S, Schmidt M, Lithgow GJ and Andersen J, 2017. ROLE OF PHARMACOLOGICALLY INDUCED-TFEB IN AGING AND AGE-RELATED NEURODEGENERATION. Innovation in Aging 1: 1224–1224.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
